CN114565326A - Medicine management method and system based on Internet of things - Google Patents
Medicine management method and system based on Internet of things Download PDFInfo
- Publication number
- CN114565326A CN114565326A CN202210463108.9A CN202210463108A CN114565326A CN 114565326 A CN114565326 A CN 114565326A CN 202210463108 A CN202210463108 A CN 202210463108A CN 114565326 A CN114565326 A CN 114565326A
- Authority
- CN
- China
- Prior art keywords
- information
- chain
- feedback
- alliance
- event
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 207
- 229940079593 drug Drugs 0.000 title claims abstract description 104
- 238000007726 management method Methods 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 28
- 238000012544 monitoring process Methods 0.000 claims abstract description 11
- 238000012790 confirmation Methods 0.000 claims description 47
- 238000012795 verification Methods 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 238000012546 transfer Methods 0.000 claims description 3
- 206010067484 Adverse reaction Diseases 0.000 abstract description 19
- 230000006838 adverse reaction Effects 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 13
- 230000009286 beneficial effect Effects 0.000 abstract description 7
- 238000007689 inspection Methods 0.000 abstract description 5
- 230000008569 process Effects 0.000 description 11
- 230000001960 triggered effect Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- 238000007405 data analysis Methods 0.000 description 4
- 238000013500 data storage Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000013524 data verification Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Social work or social welfare, e.g. community support activities or counselling services
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Y—INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR THE INTERNET OF THINGS [IoT]
- G16Y10/00—Economic sectors
- G16Y10/60—Healthcare; Welfare
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P90/00—Enabling technologies with a potential contribution to greenhouse gas [GHG] emissions mitigation
- Y02P90/30—Computing systems specially adapted for manufacturing
Landscapes
- Business, Economics & Management (AREA)
- Engineering & Computer Science (AREA)
- Economics (AREA)
- Strategic Management (AREA)
- Tourism & Hospitality (AREA)
- Health & Medical Sciences (AREA)
- Human Resources & Organizations (AREA)
- General Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Primary Health Care (AREA)
- Physics & Mathematics (AREA)
- Marketing (AREA)
- General Health & Medical Sciences (AREA)
- Entrepreneurship & Innovation (AREA)
- Theoretical Computer Science (AREA)
- Development Economics (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Accounting & Taxation (AREA)
- Bioethics (AREA)
- Computing Systems (AREA)
- Educational Administration (AREA)
- Child & Adolescent Psychology (AREA)
- Game Theory and Decision Science (AREA)
- Operations Research (AREA)
- Quality & Reliability (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The invention discloses a medicine management method and system based on the Internet of things, wherein the method comprises the following steps: the alliance chain receives medicine information and circulation information uploaded by alliance members; the public link receives treatment information sent by a user and broadcasts the treatment information to the alliance link, the treatment information comprises case information, medication information and feedback information, and the feedback information comprises negative feedback; the alliance chain broadcasts the treatment information on the chain so as to register the treatment information on the alliance chain, and an intelligent contract is called and executed according to the treatment information, and when the accumulated quantity of negative feedback in the treatment information sent by different users of the same medicine reaches a preset value, the intelligent contract triggers a feedback event; and when monitoring the feedback event on the alliance chain, the supervision platform requests the circulation information of the related medicines from the alliance chain. The drug management method and the drug management system are beneficial to truly and comprehensively reflecting the curative effect, the adverse reaction and the like of the drug, and are beneficial to forward feedback and follow-up of market inspection after the drug is on the market.
Description
Technical Field
The invention relates to the technical field of medicine management, in particular to a medicine management method and system based on the Internet of things.
Background
The medicine is different from general articles and is related to the health of people, so the medicine has strict management requirements to ensure the quality of the medicine, improve the curative effect of the medicine, ensure the medication safety of people and maintain the health of people. In the related technology, the management and the tracing of the drug information can be realized by scanning the 20-bit supervision code of the drug in the factory circulation process of the drug. However, after the drug is delivered to the end user, the drug cannot be monitored and fed back, although the drug needs to be subjected to a three-phase clinical test before being listed, after the new drug is approved to be listed, further research needs to be carried out to investigate the curative effect and adverse reaction of the drug under the condition of wide use, which is called a four-phase clinical test.
Disclosure of Invention
The present invention is directed to solving, at least to some extent, one of the technical problems in the related art. Therefore, the invention aims to provide a medicine management method and system based on the Internet of things.
In order to achieve the above object, in one aspect, a drug management method based on the internet of things according to an embodiment of the present invention includes:
the alliance chain receives medicine information and circulation information uploaded by alliance members, and broadcasts the medicine information and the circulation information on the chain so that the medicine information and the circulation information are registered on the alliance chain, wherein the alliance members comprise production enterprises, medical institutions and drug stores;
the public link receives treatment information sent by a user and broadcasts the treatment information to the alliance link, wherein the treatment information comprises case information, medication information and feedback information, and the feedback information comprises negative feedback;
the alliance chain broadcasts the treatment information on the chain so as to register the treatment information on the alliance chain, an intelligent contract is called and executed according to the treatment information, and when the accumulated quantity of the negative feedback in the treatment information sent by different users of the same medicine reaches a preset value, the intelligent contract triggers a feedback event;
and when monitoring a feedback event on a alliance chain, the supervision platform requests the circulation information of the related medicines from the alliance chain.
According to one embodiment of the invention, the federation chain includes an authentication node and a consensus node; the alliance chain receives medicine information and circulation information uploaded by alliance members, and broadcasts on the chain so that the medicine information and the circulation information are registered on the alliance chain, wherein the alliance chain comprises the following steps:
the authentication node receives medicine information and circulation information uploaded by coalition members and verifies the identity information of each node in circulation according to the medicine information and the circulation information;
and after the identity information of each node in the circulation passes the verification, broadcasting the medicine information and the circulation information to the consensus node so that the consensus node registers and accounts the medicine information and the circulation information according to a consensus algorithm.
According to one embodiment of the invention, the federation chain further includes cross-chain nodes;
the alliance chain broadcasts the treatment information on the chain so as to register the treatment information on the alliance chain, and an intelligent contract is called and executed according to the treatment information, when the accumulated quantity of the negative feedback in the treatment information sent by the same drug user reaches a preset value, the intelligent contract triggering feedback event comprises the following steps:
the cross-link node receives the treatment information broadcasted by the public link and broadcasts the treatment information to the consensus node, so that the consensus node registers and accounts the treatment information according to a consensus algorithm;
the cross-link node calls an intelligent contract according to the treatment information, and judges the accumulated quantity of negative feedback in the treatment information through the intelligent contract;
when the accumulated negative feedback quantity of the treatment information of the same medicine reaches a preset value, the feedback event is triggered, and the feedback event and the corresponding medicine information are subjected to association marking and then broadcast to a consensus node, so that the consensus node performs registration of the feedback event.
According to an embodiment of the present invention, after the intelligent contract triggers the feedback event, the method further includes:
the intelligent contract generates contribution parameters according to the quantity of the treatment information contributed by the same user in different feedback events, and the alliance chain broadcasts the contribution parameters to the public chain;
generating an incentive token according to the contribution parameters of each user by an incentive contract on the public chain;
and transmitting the incentive token as the reward of the user according to the wallet address of each user by the incentive contract on the public chain, wherein the case information comprises the wallet address.
According to an embodiment of the present invention, after the intelligent contract triggers the feedback event, the method further includes:
after monitoring the feedback event, the supervision platform inquires treatment information of a user related to the feedback event from the public chain according to the feedback event;
and acquiring the case information and the medication information from the treatment information, matching the case information and the medication information through a sample model according to the case information and the medication information, and judging the medication reasonability of the user.
According to an embodiment of the present invention, after the intelligent contract triggers the feedback event, the method further includes:
when the supervision platform judges that the treatment scheme is unreasonable, first marking information is generated, and the feedback event is marked through the first marking information to form a first confirmation event; when the supervision platform judges that the treatment scheme is reasonable, second marking information is generated, and the feedback event is marked through the second marking information to form a second confirmation event;
uploading the first and second confirmation events to a federation chain for registration by the federation chain.
According to an embodiment of the present invention, the uploading the first and second confirmation events to a federation chain includes:
the public chain receives an event request sent by a user and broadcasts the event request to the alliance chain;
the alliance chain sends a corresponding first confirmation event and/or a second confirmation event to the public chain according to the event request;
and the public chain sends the first confirmation event and/or the second confirmation event to the user.
According to an embodiment of the present invention, the uploading the first and second confirmation events to a federation chain includes:
and the alliance chain sends the first confirmation event and/or the second confirmation event to corresponding alliance members according to the medicine information and the circulation information.
According to an embodiment of the present invention, the uploading the first and second confirmation events to a federation chain network includes:
the alliance chain receives verification information uploaded and registered by alliance members, wherein the verification information is return visit information obtained by the alliance members through return visits of users to whom medicine flows are transferred;
the supervision platform periodically requests the verification information from the federation chain and saves the verification information.
On the other hand, the medicine management system based on the internet of things provided by the embodiment of the invention comprises:
the alliance chain is used for receiving the medicine information and the circulation information uploaded by the alliance members, and broadcasting the medicine information and the circulation information on the chain so that the medicine information and the circulation information are registered on the alliance chain, wherein the alliance members comprise production enterprises, medical institutions and drug stores;
the public chain is used for receiving treatment information sent by a user and broadcasting the treatment information to the alliance chain, wherein the treatment information comprises case information, medication information and feedback information, and the feedback information comprises negative feedback;
the alliance chain is further used for broadcasting the treatment information on the chain so as to register the treatment information on the alliance chain, calling and executing an intelligent contract according to the treatment information, and when the accumulated quantity of the negative feedback in the treatment information sent by different users of the same medicine reaches a preset value, the intelligent contract triggers a feedback event;
the monitoring platform is used for requesting the drug information and the circulation information of related drugs from the alliance chain when a feedback event on the alliance chain is monitored.
According to the medicine management method and system based on the Internet of things, provided by the embodiment of the invention, the medicine information and the circulation information can be uploaded to a alliance chain through alliance members such as production enterprises, medical institutions and drug stores, and then data storage and tracing of the medicines on the block chain are realized. In addition, more importantly, the treatment information can be uploaded to a public chain by a user using a terminal medicine, and then the treatment information is broadcasted to the alliance chain through the public chain, the treatment information comprises feedback information of the user, the alliance chain can call and execute an intelligent contract according to the treatment information, when the accumulated quantity of negative feedback in the treatment information sent by different users of the same medicine reaches a preset value, the intelligent contract triggers a feedback event, and when a supervision platform monitors the feedback event on the alliance chain, the supervision platform requests the circulation information of related medicines to the alliance chain, so that the supervision platform can obtain the feedback events on one hand, and can collect the curative effect, adverse reaction and the like of the medicine from the feedback event, the data quantity is large, and is reliable data on the chain, thereby being beneficial to truly and comprehensively reflecting the curative effect, the adverse reaction and the like of the medicine, and on the other hand, subsequent tracking, can be further carried out through the medicine information and the circulation information of the related medicines, Testing, data analysis, etc., which facilitates positive feedback and follow-up of post-marketing market testing of drugs.
Additional aspects and advantages of the invention will be set forth in part in the description which follows and, in part, will be obvious from the description, or may be learned by practice of the invention.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to the structures shown in the drawings without creative efforts.
FIG. 1 is a flowchart of a first embodiment of a method for Internet of things based drug management of the present invention;
FIG. 2 is a flowchart of a second embodiment of the Internet of things-based drug management method of the present invention;
FIG. 3 is a flowchart of a third embodiment of the Internet of things-based drug management method of the present invention;
FIG. 4 is a flowchart of a fourth embodiment of the Internet of things-based drug management method of the present invention;
FIG. 5 is a flowchart of a fifth embodiment of the Internet of things-based drug management method of the present invention;
fig. 6 is a schematic structural diagram of an embodiment of the internet-of-things-based drug management system of the present invention.
The implementation, functional features and advantages of the objects of the present invention will be further explained with reference to the accompanying drawings.
Detailed Description
Reference will now be made in detail to embodiments of the present invention, examples of which are illustrated in the accompanying drawings, wherein like or similar reference numerals refer to the same or similar elements or elements having the same or similar function throughout. The embodiments described below with reference to the accompanying drawings are illustrative only for the purpose of explaining the present invention, and are not to be construed as limiting the present invention.
Before explaining the embodiments of the present invention in detail, some terms related to the embodiments of the present invention are explained.
The block chain is a novel application mode of computer technologies such as distributed data storage, point-to-point transmission, a consensus mechanism, an encryption algorithm and the like. Meanwhile, the block chain is a unique mode of storing data by using encryption currencies such as bitcoin and the like, is a self-reference data structure and is used for storing a large amount of transaction information, and each record is orderly linked from back to front, so that the block chain has the characteristics of openness and transparency, incapability of being tampered and convenience in tracing. The block chain structure technology is realized through the technical principle of extensible distributed accounting with digital abstract verification, and can be used for ensuring the safety of multi-party participation transactions.
An intelligent contract is a computer protocol intended to propagate, validate or execute contracts in an informational manner. Users trade, share data, establish trust by using the intelligent contract, and ensure the storage, reading and execution of data by the characteristics of the blockchain technology, wherein the data is transparently traceable and is not falsifiable. The consensus mechanism is a mathematical algorithm for establishing trust and obtaining rights and interests among different nodes in the block chain network.
Public chain refers to a chain of blocks that anyone worldwide can read, send, and effectively confirm a transaction, and can also participate in the consensus process. Each node on the public chain can freely join and leave the network, and participate in reading and writing of data on the chain, the reading and writing are interconnected and intercommunicated in a flat topological structure, and no centralized service end node exists in the network.
And the alliance chain only aims at members of a certain specific group and limited third parties, a plurality of preselected nodes are internally designated as bookers, the generation of each block is jointly determined by all the preselected nodes, other access nodes can participate in transactions, but the billing process is not asked, and other third parties can carry out limited query through an API opened by the block chain.
Referring to fig. 1, fig. 1 is a flowchart illustrating an embodiment of a method for drug management based on the internet of things according to an embodiment of the present invention, and for convenience of description, only portions related to the embodiment of the present invention are shown. Specifically, the medicine management method based on the internet of things specifically comprises the following steps:
s101, the alliance chain 100 receives medicine information and circulation information uploaded by alliance members, and broadcasts the medicine information and the circulation information on the chain so that the medicine information and the circulation information are registered on the alliance chain 100, wherein the alliance members comprise production enterprises, medical institutions and drug stores.
Specifically, the alliance chain 100 can be formed by participation of a production enterprise, a medical institution, a pharmaceutical company, a pharmacy and the like of a medicine, wherein the production enterprise, the medical institution, the pharmaceutical company and the pharmacy are all used as alliance chain nodes in the alliance chain 100, the medicine is produced and delivered from the production enterprise, and in the process of transferring to a hospital, a medical enterprise and a pharmacy, medicine information and transfer information are uploaded to the alliance chain nodes by the production enterprise, the medical institution, the pharmaceutical company and the pharmacy and then broadcast in the network of the alliance chain 100, so that the medicine information and the transfer information are registered and stored in the alliance chain 100, and therefore medicine supervision and tracing in the whole process of medicine circulation can be ensured.
S102, the public chain 200 receives treatment information sent by a user, and broadcasts the treatment information to the alliance chain 100, wherein the treatment information comprises case information, medication information and feedback information, and the feedback information comprises negative feedback.
The user usually obtains the prescription medicine after the diagnosis in the hospital or directly purchases the corresponding medicine through a pharmacy, the user can register and input the case information, the medicine information and the feedback information after the medicine is taken through the mobile phone or the terminal device, for example, positive feedback such as improvement of the state of an illness, rehabilitation and the like, negative feedback such as a certain side effect of the medicine and the like, and the treatment information can be submitted to the public chain 200 through the mobile phone or other terminal devices. The public chain 200 can be read and participated by any person, and has a great number of nodes, so that the public chain is more friendly to a terminal user, is beneficial to the user to participate in a feedback link of treatment information, and realizes uplink registration of the feedback information. In addition, the public chain 200 may broadcast treatment information to the federation chain 100, and the federation chain 100 may register the treatment information.
S103, the alliance chain 100 broadcasts the treatment information on the chain so as to register the treatment information on the alliance chain 100, and intelligent contracts are called and executed according to the treatment information, and when the accumulated number of the negative feedbacks in the treatment information sent by different users of the same medicine reaches a preset value, the intelligent contracts trigger feedback events.
That is, the federation chain 100 performs broadcast registration on the federation chain 100 with treatment information broadcast by the public chain 200. And, intelligent contract is deployed on the alliance chain 100, and the intelligent contract can be triggered and executed through treatment information, and the intelligent contract is configured to trigger a feedback event when the accumulated number of negative feedback in the treatment information sent by different users of the same medicine reaches a preset value. For example, there are many users whose treatment information includes feedback of the same adverse reaction. It should be noted that adverse reactions before the drug is marketed usually cannot be covered in some special groups or special users, such as some special constitutional users, users with certain diseases, and the like. When the accumulated number of negative feedbacks reaches a preset value, a feedback event is triggered, which indicates that the adverse reaction is possibly present in some special groups or special users, therefore, some adverse reactions and the like which are not found in clinical tests can be found through the feedback event.
S104, when the monitoring platform 300 monitors a feedback event on the alliance chain 100, requesting the alliance chain 100 for the circulation information of the related drugs.
The administration platform 300 may be a service platform for a drug administration unit or a third party authority to participate in administration. The supervision platform 300 monitors the alliance chain 100, periodically queries the event records on the alliance chain 100, and when a feedback event is monitored, requests circulation information of the relevant drugs in the feedback event from the alliance chain 100. The corresponding medicine and the information of each node in circulation can be obtained through circulation information, so that the follow-up processing of tracing and detection analysis, such as characteristic analysis of adverse reactions for the users, can be conveniently carried out.
According to the medicine management method based on the internet of things provided by the embodiment of the invention, through coalition members such as manufacturing enterprises, medical institutions and drug stores, medicine information and circulation information can be uploaded to the coalition chain 100, and then data storage and tracing of medicines on the block chain are realized. In addition, more importantly, for a user taking medicine at a terminal, the treatment information can be uploaded to the public chain 200 and then broadcasted to the alliance chain 100 through the public chain 200, the treatment information comprises feedback information of the user, the alliance chain 100 can call and execute an intelligent contract according to the treatment information, when the accumulated quantity of negative feedback in the treatment information sent by different users of the same medicine reaches a preset value, the intelligent contract triggers a feedback event, and when the supervision platform 300 monitors the feedback event on the alliance chain 100, the supervision platform 300 requests the circulation information of related medicines to the alliance chain 100, so that the supervision platform 300 can obtain the feedback events on one hand, and can collect the curative effect, adverse reaction and the like of the medicine from the feedback event, and the data size is large, and is reliable data on the chain, which is beneficial to truly and comprehensively reflect the curative effect, adverse reaction and the like of the medicine, on the other hand, follow-up tracking, inspection, data analysis and the like can be carried out through the medicine information and the circulation information of the related medicines, and the forward feedback and follow-up of market inspection after the medicines are listed are facilitated.
In one embodiment of the invention, the federation chain 100 includes an authentication node and a consensus node; step S101 includes:
and the authentication node receives the medicine information and the circulation information uploaded by the coalition members and verifies the identity information of each node in the circulation according to the medicine information and the circulation information.
And after the identity information of each node in the circulation passes the verification, broadcasting the medicine information and the circulation information to the consensus node so that the consensus node registers and accounts the medicine information and the circulation information according to a consensus algorithm.
That is to say, in this embodiment, the authentication node verifies the identity of each node in the circulation information uploaded by the coalition members, and after the identity information is verified, the drug information and the circulation information are uplink-registered. The supervision in the drug circulation process is ensured through the authentication of the node identities, the data on the chain are purified, the identity legality of each node in the circulation process is ensured, and the drug safety is further ensured.
In one embodiment of the invention, federation chain 100 also includes cross-chain nodes; the step 103 comprises:
the cross-link nodes receive the treatment information broadcast by the public chain 200 and broadcast the treatment information to the consensus nodes, so that the consensus nodes register and account the treatment information according to a consensus algorithm;
calling an intelligent contract according to the treatment information by the cross-link points, and judging the accumulated quantity of negative feedback in the treatment information through the intelligent contract;
when the accumulated quantity of the negative feedbacks of the treatment information of the same medicine reaches a preset value, triggering the feedback event, and broadcasting the feedback event and the corresponding medicine information to a consensus node after carrying out association marking, so that the consensus node carries out registration of the feedback event.
That is, in the alliance chain 100, the interlink node may receive the therapy information broadcasted by the public chain by performing data interaction with the public chain 200, and broadcast the therapy information to the common node, so as to perform uplink registration of the therapy information by the common node. In addition, the intelligent contract is deployed on the chain-crossing node, the intelligent contract is triggered to be executed according to the treatment information through the chain-crossing node, the intelligent contract carries out quantity accumulation on negative feedback in the treatment information, the obtained accumulated quantity is compared with a preset value, when the accumulated quantity of the negative feedback is larger than or equal to the preset value, a feedback event is triggered, the feedback event and the corresponding medicine information are subjected to correlation marking and then are broadcasted to the consensus node, and the feedback event is registered through the consensus node. For example, if the cumulative number of a certain adverse reaction reaches a predetermined value, an adverse reaction event is triggered, and the adverse reaction event is associated with the drug information of the drug causing the adverse reaction, so that the supervision platform 300 can obtain the corresponding drug information and the adverse reaction event, so as to effectively supervise the drug.
Referring to fig. 2, in some embodiments of the present invention, the triggering of the feedback event by the smart contract further includes:
s201, the intelligent contract generates contribution parameters according to the amount of the treatment information contributed by the same user in different feedback events, and the alliance chain 100 broadcasts the contribution parameters to the public chain 200.
S202, generating an incentive token according to the contribution parameters of each user by the incentive contract on the public chain 200.
And S203, sending the incentive token as the reward of the user according to the wallet address of each user by the incentive contract on the public chain 200, wherein the case information comprises the wallet address.
The same user may take multiple drugs over a period of time for which there may be multiple treatment information, with the final feedback generating different feedback events. In this embodiment, the contribution parameter may be generated according to the total amount of treatment information contributed by the user at these different feedback events, and the contribution parameter is broadcast to the public chain 200 through the federation chain 100. The incentive contract is deployed on the public chain 200, the incentive contract also belongs to an intelligent contract, an incentive token (virtual token) is generated according to the contribution parameters by utilizing the incentive contract on the public chain 200, and the incentive token is sent to the wallet of the user who contributes the treatment information, so that the user can obtain the reward of feedback. The token can be circulated between the coalition members and the users, and can be used for deduction or payment when purchasing medicines.
Thus, in this embodiment, the activation of token configuration can promote the user to actively feed back the treatment information, so that the feedback mechanism for maintaining the medicine can be effectively performed.
Referring to fig. 3, in an embodiment of the present invention, after the intelligent contract triggers the feedback event, the method further includes:
s301, after the monitoring platform 300 monitors the feedback event, querying the public chain 200 for the treatment information of the user related to the feedback event according to the feedback event.
S302, acquiring the case information and the medication information from the treatment information, matching the case information and the medication information through a sample model according to the case information and the medication information, and judging the medication reasonableness of the user.
That is, the monitoring platform 300 may query the public chain 200 for the treatment information of the user related to the feedback event, since the curative effect of the drug and the like have a direct relationship with the case situation and the medication situation of the user, if the case situation and the drug are not matched, or the patient does not take the drug according to the drug administration standard, poor curative effect or other negative feedback may be caused, especially an over-the-counter drug, and the patient may purchase the drug in a pharmacy or an online store by himself or herself, resulting in mismatching between the drug and the illness state, and the like, in this embodiment, the case information and the medication information are matched with the sample model to determine whether the treatment scheme of the user is reasonable, for example, the disease a, the sample model of the general treatment scheme includes a1, a2 and the like, and after matching, if the appropriate sample model can be matched, it is described that the medication of the user is reasonable, if the matching fails, the medication is not reasonable, and illustratively, the sample model may be established according to a treatment prescription of a medical institution, so that the management personnel of the supervision platform 300 may discharge or further verify the feedback event obtained under the unreasonable condition, thereby ensuring that the feedback result is more real and effective.
Referring to fig. 4, in an embodiment of the present invention, after the intelligent contract triggers the feedback event, the method further includes:
s401, when the supervision platform 300 judges that the treatment scheme is unreasonable, first marking information is generated, and the feedback event is marked through the first marking information to form a first confirmation event; when the supervision platform 300 judges that the treatment scheme is reasonable, second marking information is generated, and the feedback event is marked through the second marking information to form a second confirmation event.
S401, uploading the first confirmation event and the second confirmation event to the alliance chain 100, so as to register through the alliance chain 100.
That is, after the supervision platform 300 determines whether the treatment plan is unreasonable, different marking information is used to mark the feedback event, the marked feedback event is called a confirmation event, for example, when the treatment plan is unreasonable, there may be a case where the dosage or method of the patient is wrong, an adverse reaction is caused, and the reaction is a distorted expression, so that after the marking is performed by the first marking information, it is convenient to distinguish which feedback events are caused by the patient's own reason, and thus, it is beneficial for the administrator of the supervision platform 300 to perform accurate tracking and data analysis. In addition, the first confirmation event and the second confirmation event formed after the marking are uploaded to the alliance chain 100, and can be queried by the alliance members, so that the alliance members can acquire related information, and can remind the users in subsequent circulation, particularly when the circulation is carried out to the terminal users, so that the users can take medicines correctly, and the like.
Referring to fig. 5, in one embodiment of the present invention, step S401 is followed by:
s501, the public chain 200 receives an event request sent by a user, and broadcasts the event request to the federation chain 100.
S502, the federation chain 100 sends a corresponding first confirmation event and/or second confirmation event to the public chain 200 according to the event request.
And S503, the public chain 200 sends the first confirmation event and/or the second confirmation event to the user.
In a specific application, a user can send an event request to the public chain 200, the public chain 200 acquires the first confirmation event and the second confirmation event from the alliance chain 100, and then sends the first confirmation event and the second confirmation event to the user, so that the user can know that the treatment scheme of the user is unreasonable according to the first confirmation event and the second confirmation event, the user can conveniently confirm and adjust the treatment scheme of the user in time, and thus, an active monitoring and reminding effect on the medication of the user can be achieved.
In one embodiment of the present invention, step S401 is followed by:
the federation chain 100 sends the first confirmation event and/or the second confirmation event to the corresponding federation members according to the drug information and the circulation information.
Specifically, the first confirmation event and/or the second confirmation event may be sent to each node in the circulation process, for example, to each hospital, pharmacy, and the like, through execution of an intelligent contract on the federation chain 100, so that the nodes can timely acquire related information, and then timely perform a callback prompt for a corresponding user, and the like.
In one embodiment of the present invention, step S401 is followed by:
the alliance chain 100 receives verification information uploaded and registered by alliance members, wherein the verification information is return visit information obtained by the alliance members returning visits to users to whom medicine flows are transferred;
the administration platform periodically requests the verification information from the federation chain 100 and saves it.
That is to say, after learning the first confirmation event and the second confirmation event, the coalition members can return visits to the users who are not rational in medication treatment in the event, and obtain return visit information, and further upload the return visit information to the coalition chain 100, and the monitoring platform periodically queries the return visit information, and then can perform mutual verification of data, so as to perform management such as tracking and analysis of the medicine more accurately.
Referring to fig. 6, the drug management system based on the internet of things according to the embodiment of the present invention includes a alliance chain 100, a public chain 200, and a supervision platform 300.
The alliance chain 100 is used for receiving medicine information and circulation information uploaded by alliance members, and broadcasting the medicine information and the circulation information on the chain so that the medicine information and the circulation information are registered on the alliance chain 100, wherein the alliance members comprise production enterprises, medical institutions and drug stores;
the public chain 200 is configured to receive treatment information sent by a user, and broadcast the treatment information to the federation chain 100, where the treatment information includes case information, medication information, and feedback information, and the feedback information includes negative feedback.
The alliance chain 100 is further used for broadcasting the treatment information on the chain, so that the treatment information is registered on the alliance chain 100, and intelligent contracts are called and executed according to the treatment information, and when the accumulated quantity of the negative feedback in the treatment information sent by different users of the same medicine reaches a preset value, the intelligent contracts trigger feedback events.
The administration platform 300 is configured to request the drug information and circulation information of the related drugs from the federation chain 100 when a feedback event on the federation chain 100 is monitored.
According to the medicine management system based on the internet of things provided by the embodiment of the invention, through coalition members such as manufacturing enterprises, medical institutions and drug stores, medicine information and circulation information can be uploaded to the coalition chain 100, and then data storage and tracing of medicines on the block chain are realized. Furthermore, more importantly, the user who uses the medicine at the terminal can upload the treatment information to the public chain 200, and then broadcast the treatment information to the alliance chain 100 through the public chain 200, the treatment information includes the feedback information of the user, and the alliance chain 100 can call and execute the intelligent contract according to the treatment information, when the accumulated quantity of the negative feedback in the treatment information sent by different users of the same medicine reaches a predetermined value, the intelligent contract triggers the feedback event, when the supervision platform 300 monitors the feedback event on the alliance chain 100, the medicine information and circulation information of the related medicine are requested to the alliance chain 100, so, on one hand, the supervision platform 300 can obtain the feedback event, the curative effect and adverse reaction of the medicine can be collected from the feedback event, and the data size is large, and the data is reliable data on the chain, which is beneficial to truly and comprehensively reflect the curative effect and adverse reaction of the medicine, and the like, on the other hand, follow-up tracking, inspection, data analysis and the like can be carried out through the medicine information and the circulation information of the related medicines, and the forward feedback and follow-up of market inspection after the medicines are listed are facilitated.
It should be noted that, in this specification, each embodiment is described in a progressive manner, and each embodiment focuses on differences from other embodiments, and portions that are the same as and similar to each other in each embodiment may be referred to. For the embodiments of the apparatus or system, since they are substantially similar to the embodiments of the method, the description is simple, and reference may be made to the partial description of the embodiments of the method for relevant points.
It is further noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. Without further limitation, an element defined by the phrase "comprising an … …" does not exclude the presence of other identical elements in a process, method, article, or apparatus that comprises the element.
The steps of a method or algorithm described in connection with the embodiments disclosed herein may be embodied directly in hardware, in a software module executed by a processor, or in a combination of the two. A software module may reside in Random Access Memory (RAM), memory, Read Only Memory (ROM), electrically programmable ROM, electrically erasable programmable ROM, registers, hard disk, a removable disk, a CD-ROM, or any other form of storage medium known in the art.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (10)
1. A medicine management method based on the Internet of things is characterized by comprising the following steps:
the alliance chain receives medicine information and circulation information uploaded by alliance members, and broadcasts the medicine information and the circulation information on the chain so that the medicine information and the circulation information are registered on the alliance chain, wherein the alliance members comprise production enterprises, medical institutions and drug stores;
the public link receives treatment information sent by a user and broadcasts the treatment information to the alliance link, wherein the treatment information comprises case information, medication information and feedback information, and the feedback information comprises negative feedback;
the alliance chain broadcasts the treatment information on the chain so as to register the treatment information on the alliance chain, an intelligent contract is called and executed according to the treatment information, and when the accumulated quantity of the negative feedback in the treatment information sent by different users of the same medicine reaches a preset value, the intelligent contract triggers a feedback event;
and when monitoring a feedback event on a alliance chain, the supervision platform requests the circulation information of the related medicines from the alliance chain.
2. The internet of things-based drug management method of claim 1, wherein the federation chain includes an authentication node and a consensus node; the alliance chain receives medicine information and circulation information uploaded by alliance members, and broadcasts on the chain so that the medicine information and the circulation information are registered on the alliance chain, wherein the alliance chain comprises the following steps:
the authentication node receives medicine information and circulation information uploaded by coalition members and verifies the identity information of each node in circulation according to the medicine information and the circulation information;
and after the identity information of each node in the flow passes the verification, broadcasting the medicine information and the flow information to the consensus node so that the consensus node registers and accounts the medicine information and the flow information according to a consensus algorithm.
3. The internet of things-based drug management method of claim 2, wherein the federation chain further comprises cross-chain nodes;
the alliance chain broadcasts the treatment information on the chain so as to register the treatment information on the alliance chain, and an intelligent contract is called and executed according to the treatment information, when the accumulated quantity of the negative feedback in the treatment information sent by the same drug user reaches a preset value, the intelligent contract triggering feedback event comprises the following steps:
the cross-link node receives the treatment information broadcasted by the public link and broadcasts the treatment information to the consensus node, so that the consensus node registers and accounts the treatment information according to a consensus algorithm;
the cross-link node calls an intelligent contract according to the treatment information, and judges the accumulated quantity of negative feedback in the treatment information through the intelligent contract;
when the accumulated quantity of the negative feedbacks of the treatment information of the same medicine reaches a preset value, triggering the feedback event, and broadcasting the feedback event and the corresponding medicine information to a consensus node after carrying out association marking, so that the consensus node carries out registration of the feedback event.
4. The method for drug management based on the internet of things of claim 1, wherein the intelligent contract further comprises after triggering a feedback event:
the intelligent contract generates contribution parameters according to the quantity of the treatment information contributed by the same user in different feedback events, and the alliance chain broadcasts the contribution parameters to the public chain;
generating an incentive token according to the contribution parameters of each user by an incentive contract on the public chain;
and transmitting the incentive token as the reward of the user according to the wallet address of each user by the incentive contract on the public chain, wherein the case information comprises the wallet address.
5. The method for drug management based on the internet of things of claim 1, wherein the intelligent contract further comprises after triggering a feedback event:
after monitoring the feedback event, the supervision platform inquires treatment information of a user related to the feedback event from the public chain according to the feedback event;
and acquiring the case information and the medication information from the treatment information, matching the case information and the medication information through a sample model according to the case information and the medication information, and judging the rationality of the treatment scheme of the user.
6. The internet of things-based drug management method of claim 5, wherein the intelligent contract further comprises, after triggering a feedback event:
when the supervision platform judges that the treatment scheme is unreasonable, first marking information is generated, and the feedback event is marked through the first marking information to form a first confirmation event; when the supervision platform judges that the treatment scheme is reasonable, second marking information is generated, and the feedback event is marked through the second marking information to form a second confirmation event;
uploading the first and second confirmation events to a federation chain for registration by the federation chain.
7. The internet of things-based drug management method of claim 6, wherein uploading the first and second confirmation events to a federation chain comprises:
the public chain receives an event request sent by a user and broadcasts the event request to the alliance chain;
the alliance chain sends a corresponding first confirmation event and/or a second confirmation event to the public chain according to the event request;
and the public chain sends the first confirmation event and/or the second confirmation event to the user.
8. The internet of things-based drug management method of claim 6, wherein uploading the first and second confirmation events to a federation chain comprises:
and the alliance chain sends the first confirmation event and/or the second confirmation event to corresponding alliance members according to the medicine information and the circulation information.
9. The internet of things-based drug management method of claim 8, wherein uploading the first and second confirmation events to a federation chain network comprises:
the alliance chain receives verification information uploaded and registered by alliance members, wherein the verification information is return visit information obtained by the alliance members through return visits of users to whom medicine flows are transferred;
the supervision platform periodically requests the verification information from the federation chain and saves the verification information.
10. A medicine management system based on the Internet of things is characterized by comprising:
the alliance chain is used for receiving the medicine information and the circulation information uploaded by the alliance members, and broadcasting the medicine information and the circulation information on the chain so that the medicine information and the circulation information are registered on the alliance chain, wherein the alliance members comprise production enterprises, medical institutions and drug stores;
the public chain is used for receiving treatment information sent by a user and broadcasting the treatment information to the alliance chain, wherein the treatment information comprises case information, medication information and feedback information, and the feedback information comprises negative feedback;
the alliance chain is further used for broadcasting the treatment information on the chain so as to register the treatment information on the alliance chain, calling and executing an intelligent contract according to the treatment information, and when the accumulated quantity of the negative feedback in the treatment information sent by different users of the same medicine reaches a preset value, the intelligent contract triggers a feedback event;
a supervision platform for requesting the transfer information of a related drug from a federation chain when a feedback event on the federation chain is monitored.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210463108.9A CN114565326B (en) | 2022-04-29 | 2022-04-29 | Medicine management method and system based on Internet of things |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210463108.9A CN114565326B (en) | 2022-04-29 | 2022-04-29 | Medicine management method and system based on Internet of things |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114565326A true CN114565326A (en) | 2022-05-31 |
| CN114565326B CN114565326B (en) | 2022-08-30 |
Family
ID=81720942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210463108.9A Active CN114565326B (en) | 2022-04-29 | 2022-04-29 | Medicine management method and system based on Internet of things |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114565326B (en) |
Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108848081A (en) * | 2018-06-01 | 2018-11-20 | 深圳崀途科技有限公司 | The data sharing method of verification and integral incentive mechanism is stored based on alliance's chain |
| CN109326337A (en) * | 2018-09-06 | 2019-02-12 | 西安电子科技大学 | Electronic medical record storage and shared model and method based on block chain |
| CN109685486A (en) * | 2018-11-28 | 2019-04-26 | 杭州云象网络技术有限公司 | A kind of polymeric chain framework based on block chain technology |
| CN109829726A (en) * | 2019-01-09 | 2019-05-31 | 上海物融智能科技有限公司 | A kind of drug information management method and system based on block chain |
| CN109859024A (en) * | 2019-01-23 | 2019-06-07 | 陕西优米数据技术有限公司 | A kind of tax system common recognition method based on alliance's chain |
| WO2020049656A1 (en) * | 2018-09-05 | 2020-03-12 | 学校法人法政大学 | Medical information management system and member device used in same |
| CN111431940A (en) * | 2020-04-28 | 2020-07-17 | 安徽农业大学 | Block chain technology-based dry fruit supply chain information tamper-proof implementation method |
| CN112163869A (en) * | 2020-09-30 | 2021-01-01 | 微医云(杭州)控股有限公司 | Block chain-based drug tracing method, device, server and medium |
| CN113591161A (en) * | 2021-08-19 | 2021-11-02 | 北京优品三悦科技发展有限公司 | Alliance chain management method, device, equipment and storage medium |
| CN113965329A (en) * | 2021-10-25 | 2022-01-21 | 浙江师范大学 | Cross-chain interoperation system, method, medium and data processing terminal |
| CN114006920A (en) * | 2021-10-11 | 2022-02-01 | 重庆电子工程职业学院 | Geological disaster emergency command system based on alliance chain |
| CN114283949A (en) * | 2021-11-08 | 2022-04-05 | 湖南云视数据科技有限责任公司 | ADR (adaptive Doppler ratio) aided decision making system based on deep learning |
| CN114389933A (en) * | 2021-12-06 | 2022-04-22 | 天翼电子商务有限公司 | Platform alliance treatment system and method |
-
2022
- 2022-04-29 CN CN202210463108.9A patent/CN114565326B/en active Active
Patent Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108848081A (en) * | 2018-06-01 | 2018-11-20 | 深圳崀途科技有限公司 | The data sharing method of verification and integral incentive mechanism is stored based on alliance's chain |
| WO2020049656A1 (en) * | 2018-09-05 | 2020-03-12 | 学校法人法政大学 | Medical information management system and member device used in same |
| CN109326337A (en) * | 2018-09-06 | 2019-02-12 | 西安电子科技大学 | Electronic medical record storage and shared model and method based on block chain |
| CN109685486A (en) * | 2018-11-28 | 2019-04-26 | 杭州云象网络技术有限公司 | A kind of polymeric chain framework based on block chain technology |
| CN109829726A (en) * | 2019-01-09 | 2019-05-31 | 上海物融智能科技有限公司 | A kind of drug information management method and system based on block chain |
| CN109859024A (en) * | 2019-01-23 | 2019-06-07 | 陕西优米数据技术有限公司 | A kind of tax system common recognition method based on alliance's chain |
| CN111431940A (en) * | 2020-04-28 | 2020-07-17 | 安徽农业大学 | Block chain technology-based dry fruit supply chain information tamper-proof implementation method |
| CN112163869A (en) * | 2020-09-30 | 2021-01-01 | 微医云(杭州)控股有限公司 | Block chain-based drug tracing method, device, server and medium |
| CN113591161A (en) * | 2021-08-19 | 2021-11-02 | 北京优品三悦科技发展有限公司 | Alliance chain management method, device, equipment and storage medium |
| CN114006920A (en) * | 2021-10-11 | 2022-02-01 | 重庆电子工程职业学院 | Geological disaster emergency command system based on alliance chain |
| CN113965329A (en) * | 2021-10-25 | 2022-01-21 | 浙江师范大学 | Cross-chain interoperation system, method, medium and data processing terminal |
| CN114283949A (en) * | 2021-11-08 | 2022-04-05 | 湖南云视数据科技有限责任公司 | ADR (adaptive Doppler ratio) aided decision making system based on deep learning |
| CN114389933A (en) * | 2021-12-06 | 2022-04-22 | 天翼电子商务有限公司 | Platform alliance treatment system and method |
Non-Patent Citations (1)
| Title |
|---|
| 鹿达等: "基于区块链的临床试验研究", 《医学信息学杂志》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114565326B (en) | 2022-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110462654B (en) | Record access and management | |
| US10817589B2 (en) | Systems and methods for improving patient compliance with a prescription drug regimen | |
| Dansereau et al. | Patient satisfaction and perceived quality of care: evidence from a cross-sectional national exit survey of HIV and non-HIV service users in Zambia | |
| CN109493939A (en) | A kind of Drug use administration method, server and computer storage medium | |
| CN108595641B (en) | Prescription information storage method, equipment, system and storage medium | |
| US8918385B1 (en) | Methods and systems of correlating electronic pharmacy data and electronic medical records | |
| US20040172447A1 (en) | Systems and methods for managing data | |
| CN111507851A (en) | Block chain-based medical insurance claim settlement processing method, device and system and storage medium | |
| CN109102358A (en) | A kind of Information Authentication method, server and storage medium | |
| Curran et al. | Daily short message service surveys to measure sexual behavior and pre-exposure prophylaxis use among Kenyan men and women | |
| CN107391942A (en) | Follow up data processing method, device, storage medium and computer equipment | |
| Bailey et al. | The Men's Safer Sex (MenSS) trial: protocol for a pilot randomised controlled trial of an interactive digital intervention to increase condom use in men | |
| CN113642034A (en) | Medical big data safety sharing method and system based on horizontal and vertical federal learning | |
| CN111403009A (en) | Hospital satisfaction investigation method and system based on block chain and computer readable storage medium | |
| Walker et al. | Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non‐inferiority trial | |
| Raj et al. | Smart Contract-Based Secure Decentralized Smart Healthcare System | |
| Rahimi et al. | Emergence of blockchain technology in the healthcare and insurance industries | |
| CN114565326B (en) | Medicine management method and system based on Internet of things | |
| Mathews et al. | Effects of enhanced STI partner notification counselling and provider-assisted partner services on partner referral and the incidence of STI diagnosis in Cape Town, South Africa: randomised controlled trial | |
| Chesterton et al. | Self-management advice, exercise and foot orthoses for plantar heel pain: the TREADON pilot and feasibility randomised trial | |
| CN109559815A (en) | A kind of information sharing method, device and relevant device | |
| CN112308563B (en) | Guest-obtaining data processing method and node | |
| CN115292745A (en) | Block chain-based medical data value circulation method | |
| CN110999262A (en) | Method and system for stimulating data exchange | |
| Rodrigues et al. | Feasibility and acceptability pilot of video-based direct observed treatment (vDOT) for supporting antitubercular treatment in South India: a cohort study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |